The combination of savolitinib and durvalumab demonstrated durable activity in a phase 2 trial of patients with papillary RCC.

迪安诊断 （ 300244 ...

Tahlia Colbert never thought cancer would be part of her story. A seemingly healthy young mother, she was focused on raising ...